ERBB2 and breast cancer: In addition, subgroup analysis of multiple clinic pathological features of BC samples in the Breast Cancer Gene-Expression Miner database showed that DYNLT1 expression is related to HER-2 status, PAM50-based intrinsic subtype, Scarff-Bloom-Richardson (SBR) grade, Nottingham prognostic index (NPI), and age and mutation status of TP53 (Figures 2A–F).